The CD133+CD44+precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma

Stem Cells and Development

Volumn 23, Issue 18, 2014, Pages 2237-2249

  Zheng, Yun Wen ^a   Tsuchida, Tomonori ^a   Shimao, Taiki ^a   Li, Bin ^a   Takebe, Takanori ^a   Zhang, Ran Ran ^a   Sakurai, Yu ^a   Ueno, Yasuharu ^a   Sekine, Keisuke ^a   Ishibashi, Naoto ^b   Imajima, Makiko ^b   Tanaka, Takuji ^c   Taniguchi, Hideki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KOWA COMPANY LTD   (Japan)

^c GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; PERETINOIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN; HYALURONIC ACID BINDING PROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROM1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CELL CLONING; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; FOLLOW UP; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; NONHUMAN; OVERALL SURVIVAL; PRECANCER; PROSPECTIVE STUDY; RAT; ANIMAL; CELL PROLIFERATION; CELL SEPARATION; FISCHER 344 RAT; LIVER TUMOR; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

AC133 ANTIGEN; ANIMALS; ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL SEPARATION; GLUTATHIONE TRANSFERASE; GLYCOPROTEINS; HYALURONAN RECEPTORS; LIVER NEOPLASMS; MALE; MOLECULAR TARGETED THERAPY; PEPTIDES; PRECANCEROUS CONDITIONS; RATS, INBRED F344;

EID: 84907000328     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0577     Document Type: Article

References (49)

1. Yamamoto J, T Kosuge, T Takayama, K Shimada, S Yamasaki, H Ozaki, N Yamaguchi and M Makuuchi. (1996). Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219-1222.
2. Singh SK, C Hawkins, ID Clarke, JA Squire, J Bayani, T Hide, RM Henkelman, MD Cusimano and PB Dirks. (2004). Identification of human brain tumour initiating cells. Nature 432:396-401.
3. O'Brien CA, A Pollett, S Gallinger and JE Dick. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110.
4. Ginestier C, MH Hur, E Charafe-Jauffret, F Monville, J Dutcher, M Brown, J Jacquemier, P Viens, CG Kleer, et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567.
5. Collins AT, PA Berry, C Hyde, MJ Stower and NJ Maitland. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951.
6. Schatton T, GF Murphy, NY Frank, K Yamaura, AM Waaga-Gasser, M Gasser, Q Zhan, S Jordan, LM Duncan, et al. (2008). Identification of cells initiating human melanomas. Nature 451:345-349.
7. Hermann PC, SL Huber, T Herrler, A Aicher, JW Ellwart, M Guba, CJ Bruns and C Heeschen. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323.
8. Ma S, KW Chan, L Hu, TK Lee, JY Wo, IO Ng, BJ Zheng and XY Guan. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542-2556.
9. Berman JJ, J Albores-Saavedra, D Bostwick, R Delellis, J Eble, SR Hamilton, RH Hruban, GL Mutter, D Page, et al. (2006). Precancer: a conceptual working definition-results of a Consensus Conference. Cancer Detect Prev 30:387-394.
10. Gao JX. (2008). Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med 12:67-96.
11. Chen L, R Shen, Y Ye, XA Pu, X Liu, W Duan, J Wen, J Zimmerer, Y Wang, et al. (2007). Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One 2:e293.
12. Zheng YW, T Tsuchida and H Taniguchi. (2012). A novel concept of identifying precancerous cells to enhance anticancer therapies. J Hepatobiliary Pancreat Sci 19:621-625.
13. Chiba T, YW Zheng, K Kita, O Yokosuka, H Saisho, M Onodera, H Miyoshi, M Nakano, Y Zen, et al. (2007). Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 133:937-950.
14. Walboomers JM, MV Jacobs, MM Manos, FX Bosch, JA Kummer, KV Shah, PJ Snijders, J Peto, CJ Meijer and N Munoz. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
15. Di Bisceglie AM, AC Lyra, M Schwartz, RK Reddy, P Martin, G Gores, AS Lok, KB Hussain, R Gish, et al. (2003). Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98:2060-2063.
16. Roskams T. (2006). Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25: 3818-3822.
17. Sell S and HA Dunsford. (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134:1347-1363.
18. Eleazar JA, L Memeo, JS Jhang, MM Mansukhani, S Chin, SM Park, JH Lefkowitch and G Bhagat. (2004). Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J Hepatol 41:983-991.
19. Fotiadu A, V Tzioufa, E Vrettou, D Koufogiannis, CS Papadimitriou and P Hytiroglou. (2004). Progenitor cell activation in chronic viralhepatitis. Liver Int 24:268-274.
20. Takaishi S, T Okumura, S Tu, SS Wang, W Shibata, R Vigneshwaran, SA Gordon, Y Shimada and TC Wang. (2009). Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27:1006-1020.
21. Yang W, HX Yan, L Chen, Q Liu, YQ He, LX Yu, SH Zhang, DD Huang, L Tang, et al. (2008). Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 68:4287-4295.
22. Yamashita T, J Ji, A Budhu, M Forgues, W Yang, HY Wang, H Jia, Q Ye, LX Qin, et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136: 1012-1024.
23. Yovchev MI, PN Grozdanov, H Zhou, H Racherla, C Guha and MD Dabeva. (2008). Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 47:636-647.
24. Suzuki A, S Sekiya, M Onishi, N Oshima, H Kiyonari, H Nakauchi and H Taniguchi. (2008). Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48:1964-1978.
25. Yin L, M Sun, Z Ilic, HL Leffert and S Sell. (2002). Derivation, characterization, and phenotypic variation of hepatic progenitor cell lines isolated from adult rats. Hepatology 35:315-324.
26. Muto Y, H Moriwaki, M Ninomiya, S Adachi, A Saito, KT Takasaki, T Tanaka, K Tsurumi, M Okuno, et al. (1996). Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334: 1561-1567.
27. Muto Y, H Moriwaki and A Saito. (1999). Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med 340:1046-1047.
28. Muto Y, M Omori and K Sugawara. (1979). Demonstration of a novel cellular retinol-binding protein, F-type, in hepatocellular carcinoma. Gann 70:215-222.
29. Muto Y and H Moriwaki. (1984). Antitumor activity of vitamin A and its derivatives. J Natl Cancer Inst 73:1389-1393.
30. Yanagitani A, S Yamada, S Yasui, T Shimomura, R Murai, Y Murawaki, K Hashiguchi, T Kanbe, T Saeki, et al. (2004). Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 40:366-375.
31. Takai K, M Okuno, I Yasuda, R Matsushima-Nishiwaki, T Uematsu, H Tsurumi, Y Shiratori, Y Muto and H Moriwaki. (2005). Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology 48:39-45.
32. Seglen PO. (1976). Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
33. Suzuki A, Y Zheng, R Kondo, M Kusakabe, Y Takada, K Fukao, H Nakauchi and H Taniguchi. (2000). Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology 32:1230-1239.
34. Suzuki A, YW Zheng, S Kaneko, M Onodera, K Fukao, H Nakauchi and H Taniguchi. (2002). Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 156:173-184.
35. Satoh K, A Kitahara, Y Soma, Y Inaba, I Hatayama and K Sato. (1985). Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci U S A 82:3964-3968.
36. Satoh K, D Yamakawa, H Sugio, K Kida, T Sato, K Hosoi and M Hayakari. (2008). Bile duct-bound growth of precursor cells of preneoplastic foci inducible in the initiation stage of rat chemical hepatocarcinogenesis by 2-acetylaminofluorene. Jpn J Clin Oncol 38:604-610.
37. Noguti J, LF Barbisan, A Cesar, CD Seabra, RB Choueri and DA Ribeiro. (2012). In vivo models for measuring placental glutatione-S-transferase (GST-P 7-7) levels: a suitable biomarker for understanding cancer pathogenesis. In Vivo 26:647-650.
38. Bisgaard HC, DC Parmelee, HA Dunsford, S Sechi and SS Thorgeirsson. (1993). Keratin 14 protein in cultured nonparenchymal rat hepatic epithelial cells: characterization of keratin 14 and keratin 19 as antigens for the commonly used mouse monoclonal antibody OV-6. Mol Carcinog 7:60-66.
39. Steinberg P, R Steinbrecher, S Radaeva, P Schirmacher, HP Dienes, F Oesch and P Bannasch. (1994). Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation. Lab Invest 71:700-709.
40. Hsia CC, RP Evarts, H Nakatsukasa, ER Marsden and SS Thorgeirsson. (1992). Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 16:1327-1333.
41. Zhang F, XP Chen, W Zhang, HH Dong, S Xiang, WG Zhang and BX Zhang. (2008). Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52:224-232.
42. Fausto N and JS Campbell. (2003). The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117-130.
43. Andersen JB, R Loi, A Perra, VM Factor, GM Ledda-Columbano, A Columbano and SS Thorgeirsson. (2010). Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 51:1401-1409.
44. Lowes KN, BA Brennan, GC Yeoh and JK Olynyk. (1999). Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 154:537-541.
45. Ogiso T, M Tatematsu, S Tamano, H Tsuda and N Ito. (1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay. Toxicol Pathol 13:257-265.
46. Moriwaki H, I Yasuda, Y Shiratori, T Uematsu, M Okuno and Y Muto. (1997). Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma. Clin Cancer Res 3:727-731.
47. Kojima S, M Okuno, R Matsushima-Nishiwaki, SL Friedman and H Moriwaki. (2004). Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review). Int J Oncol 24:797-805.
48. Okusaka T, M Makuuchi, O Matsui, H Kumada, K Tanaka, S Kaneko, H Moriwaki, N Izumi, Y Ohashi, K Okita and PS Group. (2011). Clinical benefit of peretinoin for the suppression of hepatocellular carcinoma (HCC) recurrence in patients with Child-Pugh grade A (CP-A) and small tumor: A subgroup analysis in a phase II/III randomized, placebo-controlled trial. J Clin Oncol 29(Suppl. 4):abstr 165.
49. He G, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, S Shalapour, E Seki, SE Yost, et al. (2013). Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155: 384-396.